Brokers’ Picks: MS overweight on Sun Pharma

TARGET: NA

CURRENT PRICE: Rs 949

> Recent stock price correction provides opportunity for investors to buy for mid to longer-term

> Settlement for generic Protonix patent litigation with Pfizer & Altana could negatively affect earnings estimate by 3 per cent to 4 per cent

> The company will continue to deliver strong growth over the next couple of years